What is Artiva Biotherapeutics, Inc. Common Stock's Market Cap?

Artiva Biotherapeutics, Inc. Common Stock's Market Cap is $527.5M, based on as-reported figures from SEC (XBRL) filings.

What is Artiva Biotherapeutics, Inc. Common Stock's Enterprise Value?

Artiva Biotherapeutics, Inc. Common Stock's Enterprise Value is $178.1M, based on as-reported figures from SEC (XBRL) filings.

What is Artiva Biotherapeutics, Inc. Common Stock's EV / EBITDA?

Artiva Biotherapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Artiva Biotherapeutics, Inc. Common Stock's Revenue (TTM)?

Artiva Biotherapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Artiva Biotherapeutics, Inc. Common Stock's Net Income (TTM)?

Artiva Biotherapeutics, Inc. Common Stock's Net Income (TTM) is -$90.8M, based on as-reported figures from SEC (XBRL) filings.

What is Artiva Biotherapeutics, Inc. Common Stock's EBITDA?

Artiva Biotherapeutics, Inc. Common Stock's EBITDA is -$93.5M, based on as-reported figures from SEC (XBRL) filings.

What is Artiva Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Artiva Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.86, based on as-reported figures from SEC (XBRL) filings.

What is Artiva Biotherapeutics, Inc. Common Stock's Net Debt?

Artiva Biotherapeutics, Inc. Common Stock's Net Debt is -$349.4M, based on as-reported figures from SEC (XBRL) filings.

Artiva Biotherapeutics, Inc. Common Stock (ARTV) Financial Statements

Artiva Biotherapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00VPZJ0G8

XNAS · usd

10.79▼ 0.09 (-0.83%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close10.88

Day's Range10.73 – 11.15

52-Week Range2.22 – 14.57

Volume325.0K

Avg Volume305.3K

Share Statistics

Shares Outstanding

Employees104

ExchangeXNAS

Listed2024-07-19

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Artiva Biotherapeutics, Inc. Common Stock (ARTV)

What is Artiva Biotherapeutics, Inc. Common Stock's Market Cap?: Artiva Biotherapeutics, Inc. Common Stock's Market Cap is $527.5M, based on as-reported figures from SEC (XBRL) filings.
What is Artiva Biotherapeutics, Inc. Common Stock's Enterprise Value?: Artiva Biotherapeutics, Inc. Common Stock's Enterprise Value is $178.1M, based on as-reported figures from SEC (XBRL) filings.
What is Artiva Biotherapeutics, Inc. Common Stock's EV / EBITDA?: Artiva Biotherapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Artiva Biotherapeutics, Inc. Common Stock's Revenue (TTM)?: Artiva Biotherapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Artiva Biotherapeutics, Inc. Common Stock's Net Income (TTM)?: Artiva Biotherapeutics, Inc. Common Stock's Net Income (TTM) is -$90.8M, based on as-reported figures from SEC (XBRL) filings.
What is Artiva Biotherapeutics, Inc. Common Stock's EBITDA?: Artiva Biotherapeutics, Inc. Common Stock's EBITDA is -$93.5M, based on as-reported figures from SEC (XBRL) filings.
What is Artiva Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Artiva Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.86, based on as-reported figures from SEC (XBRL) filings.
What is Artiva Biotherapeutics, Inc. Common Stock's Net Debt?: Artiva Biotherapeutics, Inc. Common Stock's Net Debt is -$349.4M, based on as-reported figures from SEC (XBRL) filings.